Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of CRAD-B.ST is 35 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell